PHARMACEUTICAL FORMULATION PROVIDING AN INCREASED BIOVAILABILITY OF HYDROPHOBIC DRUGS

Details for Australian Patent Application No. 2003291667 (hide)

International Classifications

Event Publications

8 April 2004 Complete Application Filed

Priority application(s): 60/423,184 31.10.02 US

1 July 2004 Application Open to Public Inspection

Published as AU-A-2003291667

24 May 2007 Amendment Made

The nature of the amendment is: Amend the invention title to read Pharmaceutical formulation providing an increased bioavailability of hydrophobic drugs 2004

13 September 2007 Section 223 Application Allowed

Alza Corporation The time in which to request examination has been extended to 08 May 2007. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000

28 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.